1 / 49

Physiological mechanisms of regulation of the immune system

Physiological mechanisms of regulation of the immune system. Regulation by antigen. Induce immune response and extinction Affinity maturation of B lymphocytes Maintaining immunological memory Antigenic competition Threshold density of the complexes HLA II- Ag on APC.

charleyc
Télécharger la présentation

Physiological mechanisms of regulation of the immune system

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Physiological mechanisms of regulation of the immune system

  2. Regulation by antigen • Induce immune response and extinction • Affinity maturation of B lymphocytes • Maintaining immunological memory • Antigenic competition • Threshold density of the complexes HLA II- Ag on APC

  3. Regulation by antibodies • Antibodiescompetewiththe BCR for antigen (negative regulatorof B cell stimulation) • IgGimmunecomplexesbind to the BCR andFcR on B cells→blockingof B cell activation • Regulation via idiotypic network

  4. Regulation by cytokines and cellular contact • InteractionAPC - T lymphocyte • InteractionTH1 – macrophages • InteractionTfh- B lymphocytes • MutualregulationofactivityTH1 versus TH2 • Developmentof leukocyte subpopulations

  5. Negative regulation of effector cells • CTLA-4 - T cell inhibitory receptor, binds ligands CD80 and CD86 • Self-destruction interaction of the apoptotic receptor Fas with ligand FasL on the surface of activated T cells • nhibitory receptors of NK cells

  6. Suppression mediated by T cells • Clonaleliminationoranergyof T lymphocytesaftercontactwith antigen on thesurfaceofothercellsthan APC • Regulatory T cells(Treg, Tr1, Th3 - CD 4+) help to maintain tolerance to autoantigens; produce TGF, IL-10

  7. Factors influencing the outcome of the immune response Thesame antigen caninduceanactiveimmune response oranactivestateof tolerance, theresultof response depends on many factors: • Stateoftheimmunesystem • Propertiesof antigen • Doseof antigen • Routeof antigen administration

  8. Cytokines (Tissue hormones)

  9. Cytokines • Regulatory proteins and glycoproteins produced by leukocytes and other cells • Are known as interleukins (IL-1…IL-38)(except: TNF, lymphotoxin, TGF, interferons, CSF and growth factors) • Essential regulators of the immune system • Apply also in angiogenesis, tissue regeneration, carcinogenesis, treatment of many brain functions, embryonic development ...

  10. Cytokines • Effectsofcytokines - autocrine - paracrine - endocrine • Cytokines - secreted     - membrane (CD 80, CD86, CD40L, FasL ..)

  11. Overview of the most important cytokines MF – macrophages; M – monocytes; N – neutrophils; DC – dendritic cells; NK – natural killers; L – lymphocytes; B – B cell; T – T cell

  12. Clasification of cytokines by functions Proinflammatory cytokines (IL-1, IL-6,IL- 8,IL- 12,IL- 18, TNF) Antiinflammatory cytokines(IL-4, IL-10, TGF) Cytokines with the activity of hematopoietic cells growth factor (IL-2, 3, 4, 5, 6, 7, 9, 11, 14, 15, CSF, SCF, LIF, EPO) Cytokines applying in TH2 humoral immunity(IL-4, 5, 9, 13) Cytokines applying in the cell-mediated immunity TH1 (IL-2, 12, IFN, GM-CSF, lymphotoxin) Cytokines with anti-viral effect (IFN-, IFN-, IFN- )

  13. Cytokine receptors • Consistof 2 or 3 subunits • Onesubunitbindscytokine, other are associatedwithcytoplasmicsignalingmolecules (protein kinases) • Signalingsubunitisshared by severaldifferentcytokinereceptors - called receptor family • Signalingthrough these receptorsmaylead to proliferation, differentiation, activationofeffectormechanismsorblockingthe cell cycleandinductionofapoptosis

  14. Possibilities of therapeutic affecting of the immune system

  15. Substitution treatment • autologous stem cell transplantation (following chemotherapy and radiotherapy) • treatment with intravenous immunoglobulin (derived from plasma of blood donors) • substitution of C1 inhibitor for hereditary angioedema • substitution of erythropoietin in patients with chronic renal failure • substitution of G-CSF in agranulocytosis

  16. Immunomodulation = medicalprocedure to adjustthedisruptedimmunefunction Non-specificimmunosuppression • nonspecific = affects not onlyautoreactiveandaloreactivelymphocytes, butalsoothercomponentsofimmunity (risk ofreductionantiinfectiousandantitumorimmunity) • usedfortreatmentofautoimmunediseases, for organ transplantationand severe allergicconditions

  17. Non-specific immunosuppression Corticosteroids • anti-inflammatory, immunosuppressive effects • suppress the expression of some genes (IL-2, IL-1, phospholipase A, MHC gp II, adhesion molecules) • inhibition of histamine release from basophils • higher concentrations induce apoptosis of lymfocytes

  18. Non-specific immunosuppression Immunosuppressantsaffectingthemetabolismof DNA (cytostatics) • cyclophosphamide (alkylating agent) • methotrexate (antimetabolite) • azathioprine (purine analogue)

  19. Non-specific immunosuppression Immunosuppressantselectivelyinhibiting T cells • immunosuppressive ATB: cyclosporine A, tacrolimus, rapamycin(suppresstheexpressionof IL-2 and IL-2R in activated T cells) • anti-CD3 monoclonalantibody(imunosuppressionaftertransplantation, treatmentofrejectioncrises)

  20. Anti-inflammatory and antiallergic treatment • nonsteroidal anti-inflammatory drugs • antihistamines- blocking H1 receptor                           - reduce the expression of adhesion molecules                           - reduce the secretion of histamine ... • inhibitors of inflammatory cytokine- monoclonal antibodies against TNF                           - thalidomide (TNF inhibitor) • Anti IgE antibodies (omalizumab)- severe allergic astma

  21. Non-specific immunostimulant therapy • synthetic immunomodulators • Methisoprinol (Isoprinosine) - used in viral infections with more severe or relapsing course • bacterial extracts and lysates • Broncho-Vaxom - prevention of recurrent respiratory tract infections • Ribomunyl • products of the immune system • IL-2 - renal adenocarcinoma • IFN, IFN - viral hepatitis, some leukemia • Erythropoietin – renal failure • G-CSF, GM-CSF – neutropenia

  22. Antigen-specific immunomodulation • specific immunomodulation = induce of an immune response or tolerance to a specific antigen • active immunization • passive immunization • specific immunosuppression

  23. Antigen-specific immunomodulation Activeimmunization (vaccination)= the induction of immunity after exposure toan antigen • activatesspecificcellularandhumoralimmunity • createslong-term immunity (memorycells) • protectagainst a pathogenbearingthis antigen orsimilar antigen (prophylaxis)

  24. Antigen-specific immunomodulation activeimmunization (vaccination) • vaccines are madefrominactivatedorattenuatedmicroorganismsortheirantigens(polysaccharidecapsule, toxins) • attenuated vaccines cannot be used in immunocompromisedindividuals • risk ofinfectionoranaphylacticreactions

  25. Antigen-specific immunomodulation Passiveimmunization • natural- transfer ofmaternalantibodies in fetalblood • therapeutic- the use ofanimalantibodiesagainstvarioustoxins(snaketoxins, tetanus toxin, botulinum toxin) • prophylaxis - thehumanimmunoglobulinfromimmunizedindividuals (hepatitis A, rabies, tetanus)                     - Anti-RhDantibodies – preventimmunizationofmotherwithRhD+ fetus erythrocytes • provides a temporary (3 weeks) specifichumoralimmunity • the risk anaphylacticreactions

  26. Antigen-specific immunomodulation Specificimmunosuppression= inductionof tolerance to a specific antigen • inductionof tolerance by oral administrationof antigen (treatmentofcertainautoimmunediseases) • allergenimmunotherapy (pollen, insectpoisons) Vaccinationagainstcancer • immunizationwithdendriticcells

  27. Antiinfection immunity

  28. Defence against extracellular pathogens • Bacteria, unicellularparasites • Neutrophilgranulocytes • Opsonization(C3b, IgGandIgAantibodies, lectins, CRP...)

  29. Defence against extracellular pathogens • Pathogeninduceinflammation • Neutrophils: phagocytosis, degranulation, NETs • Ingestedbacteria are destroyed by themicrobicidalsystems(productsof NADP-H oxidase, hydrolyticenzymesandbactericidalsubstances in lysosomes) • Activatedphagocytesproduceproinflammatorycytokines(IL-1, IL-6, TNF)

  30. Defence against extracellular pathogens • Pathogensactivate complement • IgM - complement activation • IgG - complement activation, opsonization • IgA - opsonizationsIgA prevents against infection by intestinal and respiratory bacteria • Neutralizing antibodies apply in the defense against bacterial toxins (Clostridium tetani and botulinum …)

  31. Defence against extracellular pathogens • „Indirect toxins“ - bacterial Lipopolysaccharide (LPS) stimulates big number of monocytes to release TNF, which can cause septic shock • Individuals with immunodeficiency of phagocytes, complement and antibodies production are especially at risk of infections with extracellular bacterial

  32. Defense against intracellular pathogens

  33. Defense against intracellular pathogens • Bacteria, fungiandunicellularparasites • Intracellularparasites are resistant to themicrobicidalmechanismsofphagocytes • Macrophagewhichengulfpathogenproduce IL-12 → TH1differentiation, productionofIFNandmembrane TNF → activationofmacrophageand NOproduction • NO killsintracellularpathogens

  34. Defense against intracellular pathogens • TClymphocytesapply in the defense againstintracelularparasites, whichescapefromphagolysosomes • Individualswithcertaindisordersofphagocytesanddefectsof T lymphocytes are at risk ofinfectionswithintracellularmicroorganisms

  35. Defense against intracellular pathogens

  36. Anti-viral defense

  37. Anti-viral defence • interferons - productionof IFNand IFNisinducedin infectedcells; IFNactivatesmacrophages (iNOS) • IFNandIFN-preventsviralreplication - induceproliferationofNK cells - increase the expression of HLA-I(AgpresentationforTc)

  38. Anti-viral defence

  39. ADCC Anti-viral defence • NK cells ADCC (Antibody-dependent cell-mediated cytotoxicity); NK cell bind with CD16 (Fcreceptor) to IgGwhich has bound to the surface of infected cell and then NK cell release perforins and granzymes

  40. Anti-viral defence • Effector TC lymphocytes destroy infected cells in direct contact (granzym/perforin; FasL) and by produced cytokines (lymfotoxin)

  41. Anti-viral defence • sIgA inhibit mucosal adhesion of viruses (defense against respiratory viruses and enteroviruses) • Neutralizing IgG and IgM antibodies activate the classical pathway of complement, that is able to lyse certain viruses • IgG and IgA opsonize viral particles • IgA and IgG have preventive effect in secondary viral infection

  42. Anti-viral defence • Somevirusesafterinfectionintegrateintothe host genome, wherepersistforyears (varicellazoster, EBV, papillomavirus) • Individualswith T lymphocyteimmunodeficiencyandwithcombinedimmunedisorders are at risk by viralinfections • Increasedsusceptibility to herpes infections in individualswithdysfunctionof NK cells

  43. Defense against multicellular parasites

  44. Defense against multicellular parasites • IgE, mast cells, basophils and eosinophils • TH2 stimulation under the influence of IL-4(mast cells and other APC stimulated by parasite) • TH2 with IL-4 production stimulate isotype switching to IgE • IgE bind to FcRI on mast cells and basophils

  45. Mast cell activation by cross-linking of IgE Fc receptors • BindingofIgE to highaffinnityFc receptor forIgE (FcRI) • Bindingof multivalent antigen (multicellular parasite) to IgE • AggregationofseveralmoleculesofFcRI

  46. Mast cell activation • Cytoplasmic granules: hydrolytic enzymes, histamine, serotonin, heparin • Activation of arachidonic acid metabolism (leukotriene C4, prostaglandin D2) • Start of cytokines production (TNF, TGF, IL-4, 5,6 ...)

  47. Defense against multicellular parasites Histamine • Vasodilatation, increasevascular permeability (erythema, edema, itching) • Bronchoconstriction(cough) • Increasesintestinalperistalsis (diarrhea) • IncreasedmucussecretionThishelpseliminatethe parasite.

  48. Defense against multicellular parasites • Eosinophils release from granules (eosinophilic katoin protein, proteases ...) • Eosinophils phagocyte complexes of parasitic particles with IgE via its IgE receptors • IL-5 activation of eosinophils

  49. Defense against multicellular parasites • eosinophils fagocyte complexesofparasiticparticleswithIgE via theirreceptorsforIgE • eosinophils use againstparasitesextracellularbactericidalsubstancesreleasedfromgranules(ECP- eosinophilcationic protein, MBP-major basic protein…) Thank you for your attention

More Related